CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −249 | $86.48 | $22K | 13,987 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −5,993 | $93.28 | $559K | 7,994 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,693 | $94.61 | $255K | 5,301 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,463 | $95.53 | $140K | 3,838 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −846 | $96.46 | $82K | 2,992 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −20 | $97.26 | $2K | 2,972 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −1,246 | 7,473 | ||
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,246 | $32.67 | $41K | 17,242 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −637 | $83.67 | $53K | 16,605 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,198 | $84.61 | $101K | 15,407 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,171 | $85.73 | $100K | 14,236 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −249 | $86.48 | $22K | 13,987 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −6,810 | $93.26 | $635K | 7,177 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −3,122 | $94.60 | $295K | 4,055 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,463 | $95.53 | $140K | 2,592 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −846 | $96.46 | $82K | 1,746 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −20 | $97.26 | $2K | 1,726 |
| 2025-04-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −1,246 | 7,473 | ||
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −2,024 | $81.16 | $164K | 46,290 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −3,134 | $82.17 | $258K | 43,156 |
Page 19 of 23 · 450 trades